Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Prelude Therapeutics (PRLD)
NASDAQ:PRLD
RESEARCH TOOLSreports
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 03, 2025 | Krishna Vaddi Ceo,director | xxxxxxxxxxxxx | $6000 |
| Jan 02, 2025 | Krishna Vaddi Ceo,director | xxxxxxxxxxxxx | $12000 |
| Dec 26, 2024 | Andrew Combs Chief Chemistry Officer | xxxxxxxxxxxxx | $81600 |
| Dec 20, 2024 | Krishna Vaddi Ceo,director | xxxxxxxxxxxxx | $99061 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,646,056 | Insider | 25.24% | 10,326,674 | |
| 10,123,824 | Institution | 24.00% | 9,820,109 | |
| 9,252,951 | Insider | 21.93% | 8,975,362 | |
| 4,908,086 | Insider | 11.10% | 4,760,843 | |
| 3,766,120 | Institution | 8.93% | 3,653,136 | |
| 999,781 | Institution | 2.37% | 969,788 | |
| 927,934 | Institution | 2.20% | 900,096 | |
| 809,844 | Institution | 1.92% | 785,549 | |
| 532,059 | Institution | 1.26% | 516,097 | |
| 500,098 | Insider | 1.19% | 485,095 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 927,934 | Institution | 2.20% | 900,096 | |
| 809,844 | Institution | 1.92% | 785,549 | |
| 327,699 | Institution | 0.78% | 317,868 | |
| 204,196 | Institution | 0.48% | 198,070 | |
| 178,089 | Institution | 0.42% | 172,746 | |
| 166,500 | Institution | 0.39% | 161,505 | |
| 151,685 | Institution | 0.36% | 147,134 | |
| 70,681 | Institution | 0.17% | 68,561 | |
| 40,990 | Institution | 0.10% | 39,760 | |
| 27,608 | Institution | 0.07% | 26,780 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 720,427 | Institution | 1.71% | 918,544 | |
| 373,782 | Institution | 0.89% | 362,569 | |
| 207,507 | Institution | 0.49% | 264,571 | |
| 126,352 | Institution | 0.30% | 122,561 | |
| 82,935 | Institution | 0.20% | 78,788 | |
| 62,686 | Institution | 0.15% | 79,925 | |
| 60,533 | Institution | 0.14% | 57,506 | |
| 30,786 | Institution | 0.07% | 29,862 | |
| 15,986 | Institution | 0.04% | 38,207 | |
| 9,161 | Institution | 0.02% | 11,680 |
FAQ
Who Owns Prelude Therapeutics (PRLD)?
Currently, no data Available
What percentage of Prelude Therapeutics (PRLD) stock is held by institutional investors?
Currently, no data Available
What percentage of Prelude Therapeutics (PRLD) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Prelude Therapeutics (PRLD)?
David Bonita owns the most shares of Prelude Therapeutics (PRLD).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.